Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases

P Kolkhir, D Elieh-Ali-Komi, M Metz… - Nature Reviews …, 2022 - nature.com
Mast cells have crucial roles in allergic and other inflammatory diseases. Preclinical
approaches provide circumstantial evidence for mast cell involvement in many diseases, but …

Siglecs as immune cell checkpoints in disease

S Duan, JC Paulson - Annual review of immunology, 2020 - annualreviews.org
Sialic acid–binding immunoglobulin-type lectins (Siglecs) are expressed on the majority of
white blood cells of the immune system and play critical roles in immune cell signaling …

[HTML][HTML] Urticaria: collegium internationale allergologicum (CIA) update 2020

M Maurer, K Eyerich, S Eyerich, M Ferrer… - International archives of …, 2020 - karger.com
This update on chronic urticaria (CU) focuses on the prevalence and pathogenesis of
chronic spontaneous urticaria (CSU), the expanding spectrum of patient-reported outcome …

Mast cells: A new frontier for cancer immunotherapy

JN Lichterman, SM Reddy - Cells, 2021 - mdpi.com
Mast cells are unique tissue-resident immune cells of the myeloid lineage that have long
been implicated in the pathogenesis of allergic and autoimmune disorders. More recently …

Targeting eosinophils in allergy, inflammation and beyond

PC Fulkerson, ME Rothenberg - Nature reviews Drug discovery, 2013 - nature.com
Eosinophils can regulate local immune and inflammatory responses, and their accumulation
in the blood and tissue is associated with several inflammatory and infectious diseases …

Biologics for the use in chronic spontaneous urticaria: when and which

M Maurer, DA Khan, DEA Komi, AP Kaplan - The Journal of Allergy and …, 2021 - Elsevier
Guidelines for the treatment of chronic spontaneous urticaria (CSU) recommend the use of
the IgE-targeted biologic omalizumab in patients with antihistamine-refractory disease. The …

New treatments for chronic urticaria

P Kolkhir, S Altrichter, M Munoz, T Hawro… - Annals of Allergy, Asthma …, 2020 - Elsevier
Objective Chronic urticaria (CU) is a common, heterogeneous, and debilitating disease.
Antihistamines and omalizumab are the mainstay therapies of CU. Additional treatment …

Anaphylaxis: lessons from mouse models

FD Finkelman - Journal of allergy and clinical immunology, 2007 - Elsevier
Studies with mouse models demonstrate 2 pathways of systemic anaphylaxis: a classic
pathway mediated by IgE, FcɛRI, mast cells, histamine, and platelet-activating factor (PAF) …

Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer

S Sivori, M Della Chiesa, S Carlomagno… - Frontiers in …, 2020 - frontiersin.org
The highly destructive mechanisms by which the immune system faces microbial infections
is under the control of a series of inhibitory receptors. While most of these receptors prevent …

The CD300 molecules: an emerging family of regulators of the immune system

F Borrego - Blood, The Journal of the American Society of …, 2013 - ashpublications.org
The CD300 family of molecules modulates a broad and diverse array of immune cell
processes via their paired activating and inhibitory receptor functions. The description that …